Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249).

Synold, Timothy W; Plets, Melissa; Tangen, Catherine M; Heath, Elisabeth I; Palapattu, Ganesh S; Mack, Philip C; Stein, Mark N; Meng, Maxwell V; Lara, Primo; Vogelzang, Nicholas J; Thompson, Ian Murchie; Ryan, Christopher W

Synold, Timothy W; Plets, Melissa; Tangen, Catherine M; Heath, Elisabeth I; Palapattu, Ganesh S; Mack, Philip C; Stein, Mark N; Meng, Maxwell V; Lara, Primo; Vogelzang, Nicholas J; Thompson, Ian Murchie; Ryan, Christopher W.

Afiliação

Synold TW; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Plets M; SWOG Statistical Center/Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Tangen CM; SWOG Statistical Center/Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Heath EI; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Palapattu GS; University of Michigan, Ann Arbor, MI, USA.
Mack PC; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Meng MV; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, A, USA.
Lara P; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
Thompson IM; The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Ryan CW; Oregon Health & Science University, OHSU Knight Cancer Institute, Portland, OR, USA.

Kidney Cancer ; 3(2): 111-118, 2019 Aug 07.

Article em En | MEDLINE | ID: mdl-31763512

Palavras-chave

Renal cell carcinoma; adjuvant chemotherapy; everolimus; pharmacokinetics; therapeutic drug monitoring

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Kidney Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google